PATHOGEN-REDUCED HUMAN PLATELET LYSATE
Vital to Clinical Progress
nLiven PRTM is a human platelet lysate (HPL) using a unique pathogen-reduction process that is GMP compliant. It is designed to meet your needs for the evolving global regulations and challenging development milestones. nLiven PR is your tool to develop therapeutics by providing:
- Safety: validated pathogen reduction in an ISO 9001 certified facility and tested for sterility, mycoplasma, and endotoxin
- Reproducibility: minimized lot-to-lot variability by pooling over 100 human U.S. donors from AABB accredited/FDA registered blood centers
- Reliability: established manufacturer, dependable supply to meet your large-scale commercialization needs, and stable pricing
- Compliance: produced under consideration of European Pharmacopoeia General Chapter 188.8.131.52
nLiven PR, vital to clinical progress.
Request a free sample bottle of nLiven PR for evaluation.
|nLiven PR 100mL||PL-PR-100|
|nLiven PR 500mL||PL-PR-500|
NOTE: No heparin added during production or required for use
nLiven PR shown on this website is not approved or available in all regulatory jurisdictions. Please consult with your local Cook Regentec representative or Customer Service for details.